These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Co-trimoxazole and warfarin: case report of an interaction. Errick JK; Keys PW Am J Hosp Pharm; 1978 Nov; 35(11):1399-401. PubMed ID: 707511 [No Abstract] [Full Text] [Related]
4. Letter: Potentiations of warfarin by co-trimoxazole. Br Med J; 1975 Jun; 2(5972):684. PubMed ID: 1139178 [No Abstract] [Full Text] [Related]
5. Potentiation of warfarin by trimethoprim-sulfamethoxazole. Kaufman JM; Fauver HE Urology; 1980 Dec; 16(6):601-3. PubMed ID: 7445308 [TBL] [Abstract][Full Text] [Related]
6. Racemic warfarin and trimethoprim-sulfamethoxazole interaction in humans. O'Reilly RA; Motley CH Ann Intern Med; 1979 Jul; 91(1):34-6. PubMed ID: 464451 [TBL] [Abstract][Full Text] [Related]
7. Combinations of antimicrobial agents. III. The in vitro sensitivity of 12 strains of Pseudomonas aeruginosa and 12 strains of proteus species ot sulphamethoxazole + trimethoprim (co-trimoxazole), polymyxins and combinations of co-trimoxazole and polymyxins. Kuipers JS Arch Chir Neerl; 1976; 28(2):91-9. PubMed ID: 823875 [TBL] [Abstract][Full Text] [Related]
10. Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man. O'Reilly RA N Engl J Med; 1980 Jan; 302(1):33-5. PubMed ID: 7350395 [No Abstract] [Full Text] [Related]
11. Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Silver BA; Bell WR Ann Intern Med; 1979 Mar; 90(3):348-9. PubMed ID: 426403 [No Abstract] [Full Text] [Related]
12. Letter: Co-trimoxazole resistance. Then R; Angehrn P Br Med J; 1974 Jan; 1(5897):78-9. PubMed ID: 4590994 [No Abstract] [Full Text] [Related]
13. Letter: Susceptibility of Bacteroides fragilis to co-trimoxazole. Okubadejo OA Lancet; 1974 May; 1(7865):1061. PubMed ID: 4133750 [No Abstract] [Full Text] [Related]
14. Effect of co-trimoxazole and sulfamethoxazole on serum creatinine in normal subjects. Roy MT; First MR; Myre SA; Cacini W Ther Drug Monit; 1982; 4(1):77-9. PubMed ID: 7071907 [TBL] [Abstract][Full Text] [Related]
15. Interaction between warfarin and sulphamethoxazole. Tilstone WJ; Gray JM; Nimmo-Smith RH; Lawson DH Postgrad Med J; 1977 Jul; 53(621):388-90. PubMed ID: 882479 [TBL] [Abstract][Full Text] [Related]
16. Antibacterial synergism: a proposal for chemotherapeutic potentiation between trimethoprim and sulfamethoxazole. Poe M Science; 1976 Oct; 194(4264):533-5. PubMed ID: 788154 [TBL] [Abstract][Full Text] [Related]
17. The effect of co-trimoxazole on serum creatinine. Dijkmans BA; van Hooff JP; de Wolff FA; Mattie H Br J Clin Pharmacol; 1981 Nov; 12(5):701-3. PubMed ID: 6977366 [TBL] [Abstract][Full Text] [Related]
18. [Potentiation by EDTA and levallorphan of the effect of sulfamethoxazole-trimethoprim on Escherichia coli]. Then R Experientia; 1972 Sep; 28(9):1118-9. PubMed ID: 4198708 [No Abstract] [Full Text] [Related]
19. In vitro resistance of haemophilus influenzae to co-trimoxazole and trimethoprim. Cornere BM; Menzies R N Z Med J; 1975 Mar; 81(536):292-4. PubMed ID: 1079587 [TBL] [Abstract][Full Text] [Related]